ISRAELI-FRENCH BREAST CANCER UPdATE Prevention

Preliminary Program
du 30 avril au 2 mai 2014
From Wednesday 30th April to Friday 2nd May 2014
Israeli-French
breast cancer
update
Prevention, Detection and treatment
A multidisciplinary approach
King David hotel
Jerusalem
traduction simultanée Français/Anglais
Organisé par / Organised by
Honor presidents
Pr Moïse NAMER (France)
Pr Jean-Michel TUBIANA (France)
Presidents
Dr Zehava GALIMIDI (Israël)
Pr Eli KONEN (Israël)
Dr Marc ESPIE (France)
Pr Jean-Luc DRAPE (France)
Scientific general secretary
Dr Luc ROTENBERG (France)
Dr Tamar SELLA (Israël)
Dr Jean-Yves SEROR (France)
Dr Tanir ALLWEIS (Israël)
Inscription / Registration
Inscription / Registration pour les membres AFIIM
à jour de droits International Medical Events (IME) / Equatour
124, Boulevard Exelmans – 75016 PARIS
Tél. : +33 1 47 43 50 00 - Fax : +33 1 47 43 50 01
AZ Voyages
121, Boulevard Soult - 75012 PARIS
Tél. : +33 1 44 67 89 03 Port. :+33 6 09 34 88 89
Contact : Adrienne LE LAIN SLAMA
e-mail : [email protected]
Contact : Jacqueline Glauberg
e-mail : [email protected]
Label FMC Fepur / CMC FEPUR Label n°10-2014-035
ISRAELI-FRENCH BREAST CANCER UPDATE
Prevention, Detection and treatment
A multidisciplinary approach
ISRAELI PRESIDENT : Dr Zehava GALIMIDI, Pr Eli KONEN
FRENCH PRESIDENT : Dr Marc ESPIE, Pr Jean-Luc DRAPE
HONOR PRESIDENT : Pr Moïse NAMER, Pr Jean-Michel TUBIANA
Scientific Secretary : Dr Tanir ALLWEIS, Dr Luc ROTENBERG, Dr Tamar SELLA, Dr Jean-Yves SEROR
SCIENTIFIC COMMITTEE
France
Dr Eric-Charles
Dr Marc
Dr Krishna
Dr David
Pr Jean Luc
Pr Marc
Dr Joseph
Dr Jean-Marc
Pr Moïse
Dr Liliane
Dr Luc
Dr Eric
Dr Jean-Yves
Pr Marc
Dr Sophie
Dr Alain
Pr Jean-Michel
ANTOINE
BOLLET
CLOUGH
COEFFIC
DRAPE
ESPIE
GLIGOROV
GUINEBRETIERE
NAMER
OLLIVIER
ROTENBERG
SEBBAN
SEROR
SPIELMANN
TAIEB
TOLEDANO
TUBIANA
Oncologist, ISHH, Neuilly-sur-Seine
Radiotherapist, ISHH, Neuilly-sur-Seine
Surgeon, Paris Breast Institute, Paris
Oncologist, Reims
Radiologist, CHU COCHIN, Paris
Oncologist, CHU Saint Louis, Paris
Oncologist, Institut Curie, Paris
Pathologist, Institut Curie, CRH, Saint Cloud
Oncologist, CHU, Nice
Radiologist, Institut Curie, Paris
Radiologist, ISHH, Neuilly-sur-Seine
Surgeon, ISHH, Neuilly-sur-Seine
Radiologist, Centre Duroc, Paris
Oncologist, Institut Gustave Roussy, Villejuif
Radiologist, Centre Oscar Lambret, Lille
Radiotherapist, American Hospital & ISHH, Neuilly-sur-Seine
Radiologist, CHU Saint Antoine, Paris
ALLWEIS
EFRAT BEN BARUCH
GALLIMIDI
HERSHKO
KADURI
KEINAN BOKER
KONEN
LEVY-LAHAD
MAIMON
PERETZ
SELLA
SHABTAI
SKLAIR-LEVY
WEISENBERG WIGODA
YERUSHALMI
ZICK Surgeon, Kaplan Medical Center
Oncologist, Kaplan Medical Center
Radiologist, Rambam Health care Campus, Haifa
Surgeon, Rambam medical Center, Haifa Oncologist, Hadassah Medical Center, Jerusalem
Epidemiologist, Israel Ministry of health
Radiologist, Chaim Sheba Medical Center, Tel Hashomer, Tel Aviv
Geneticist, Shaarei Tzedek Medical Center
Oncologist, Hadassah Medical Center, Jerusalem
Oncologist, Hadassah Medical Center, Jerusalem
Radiologist, Hadassah Medical Center, Jerusalem
Surgeon, Sheba Medical Center, Tel Aviv
Radiologist, Sheba Medical center, Tel Aviv
Radiologist, Meir Hospital Kfar Saba
Radioterapist, Hadassah Medical Center, Jerusalem
Oncologist, Rabin Medical Center Petah Tikva
Oncologist, Hadassah Medical Center, Jerusalem
Israël
Dr Tanir
Dr Noa
Dr Zehava
Pr Dan
Dr Luna
Dr Lital
Pr Eli
Pr Efrat
Dr Ofra
Pr Tamar
Dr Tamar
Pr Moshe
Dr Miri
Dr Naomi
Dr Marc
Dr Rinat
Dr Aviad
ISRAELI-FRENCH BREAST CANCER UPDATE
Prevention, Detection and treatment
A multidisciplinary approach
Mercredi 30 avril 2014 / Wednesday
April 30th 2014
u16h55 – 17h10
Oncotype DX. L’expérience israélienne Oncotype DX : Israeli exprerience.
Dr Noa EFRAT BEN BARUCH, Israël
13h00-14h00 u DÉJEUNER/LUNCH
u17h10 – 17h30
Panel discussion. Dr Eric-Charles ANTOINE (France),
Dr Marc BOLLET (France), Dr Miri SKLAIR-LEVY (Israël),
Dr Noa EFRAT BEN BARUCH (Israël),
Dr Alain TOLEDANO (France)
u14h00 - 18h00 u SESSION 1 - Neo-adjuvant (NA)
situation in breast cancer
Modérateurs / Chairmen : Pr Moshe SHABTAI (Israël),
Pr Marc ESPIE (France), Dr Eric-Charles ANTOINE (France)
u14h00 – 14h20
Biopsies en situation NA . Quelles recommandations?
Quel impact sur le traitement?
Biospy in NA. Recommandations and impact treatment.
Dr Miri SKLAIR-LEVY, Israël
u14h20 – 14h40
IRM mammaire et CT Néoadjuvante. Marqueur de
prédiction de la réponse ?
Breast MRI in NAC. A Predictive response marker ?
Dr Sophie TAIEB, France
u14h40 – 15h00
Chimiothérapie Neo Adjuvante des cancers du sein :
acquis et perspectives
Neo Adjuvant chemotherapy : present and future.
Dr Noa EFRAT BEN BARUCH, Israël
u15h00 – 15h20
Place et rôle du radiothérapeute dans le TNA des cancers
du sein
Place of radiotherapy in NA treatment.
Dr Marc BOLLET, France
u15h20 – 15h40 Rôle du chirurgien dans le traitement NA
Rule of surgeon in NA situation. Dr Tanir ALWEISS, Israël
15h40 – 16h00 uPAUSE/COFFEE BREAK
Modérateurs / Chairmen : Pr Marc SPIELMANN (France),
Pr Tamar PERETZ (Israël)
u16h00 – 16h20
Le statut BRCA peut-il influencer la proposition de
traitement médical ?
Rule of BRCA status in treatment planification.
Dr Aviad ZICK, Israël
u16h20 – 16h40
Biomarqueurs individuels de pronostic et de prédiction
Individual prognosis and predictive biomarkers.
Dr Jean Marc GUINEBRETIERE, France
u16h40
– 16h55
Test et Profil génomique. Quel avenir dans la prise en
charge ? Test and Genomic profile : what future?
Dr Alain TOLEDANO, France
u17h30 – 18h15
Symposium : Dr Eric-Charles ANTOINE (France),
Dr Joseph GLIGOROV (France)
u18h15 – 18h30
Conclusion and take home message.
Pr Marc SPIELMANN (France), Pr Tamar PERETZ (Israël),
Pr Moshe SHABTAI (Israël)
Jeudi 1er mai 2014 / Thursday may 1st
2014
u09h00 - 12h30 u SESSION 2 - Prevention,
Breast screening and diagnosis
Modérateurs / Chairmen : Dr Zahava GALLIMIDI (Israël),
Pr Jean-Luc DRAPE (France), Dr Sophie TAIEB (France)
u09h00 - 09h20
Epidémiologie du cancer du sein en France et en Israël :
similitude et différences
Breast cancer epidemiology in France and Israel :
similarities and differencies. Dr Marc ESPIE, France
u09h20 - 09h40
Dépistage en Israel : enjeux et limites
Screening in Israel : Issues and futur. ……………….Israël
u09h40 - 10h00
Facteurs de risques génétiques en Israël Genetic risk factors in Israel. Pr Efrat LEVY-LAHAD, Israël
u10h00 - 10h20
Imagerie IRM chez les femmes à risque génétique MRI in Genetic risk patient. Liliane OLLIVIER, France
u10h20 - 10h40 Panel discussion. Dr Marc ESPIE (France),
Dr Jean-Yves SEROR (France),
Dr Miri ZIV (Director General Israel Cancer Association, France)
10h40 - 10h50uPAUSE/COFFEE BREAK
ISRAELI-FRENCH BREAST CANCER UPDATE
Prevention, Detection and treatment
A multidisciplinary approach
Modérateurs / Chairmen : Pr Jean-Michel TUBIANA
(France), Dr Jean-Yves SEROR (France),
Dr Naomi WEISENBERG (Israël)
u10h50
- 11h10
Tomosynthèse mammaire : quel avenir clinique ?
Digital Breast Tomosynthesis (DBT): what clinical future?
Dr Luc ROTENBERG, France
u11h10 - 11h30
Indications de l’IRM mammaire
Breast MRI indications. Dr Sophie TAIEB, France
u11h30
- 11h50
Sénologie interventionnelle diagnostique Diagnosis Interventional procedures.
Dr Jean-Yves SEROR, France
u11h50
– 12h30
Symposium : Contrast Agents in Oncology, Selection
of Response Criteria for Clinical Trials of Cancer
Treatment
u12h30 – 12h50
Panel discussion. Dr Sophie TAIEB (France),
Dr Jean-Yves SEROR (France), Dr Zehava GALLIMIDI (Israël)
u12h50
– 13h00
Conclusion and take home message.
Dr Sophie TAIEB (France), Dr Naomi WEISENBERG (Israël)
13h00 - 14h00 u DÉJEUNER / LUNCH
u14h00 - 18h00 u SESSION 3 - Small and
precancerous lesion assessment and treatment
Modérateurs / Chairmen : Dr Joseph GLIGOROV (France),
Dr Krishna CLOUGH (France), Pr Dan HERSHKO (Israël)
u14h00
- 14h20
Les cancers ≤ 1 cm. Caractéristiques anatomopathologiques. Paramètres pronostics et prédictifs
Pathology in small lesions. Prognostic and predictive
factors. Dr Jean-Marc GUINEBRETIERE, France
u14h20 - 14h40
Le cancer du sein ≤ 1 cm. Spécificités en imagerie
Small lesions. Imaging features. Dr Jean-Yves SEROR, France
u14h40 -15h00
Le cancer du sein ≤ 1 cm. Rôle du chirurgien.
Small lesions. Role of surgeon. Dr Eric SEBBAN, France
u15h00 - 15h20
Techniques d’ablation mini-invasive : un futur réaliste ?
Minimal invasive ablation procedures. A realistic future ?
Dr Luc ROTENBERG, France
15h20 - 15h40uPAUSE/COFFEE BREAK
Modérateurs / Chairmen : Pr Moïse NAMER (France),
Pr Dan HERSHKO (Israël), Dr Alain TOLEDANO (France)
u15h40 - 16h00 Radiothérapie des petits cancers du sein
Radiotherapy in small lesion. Dr Alain TOLEDANO, France
u16h00 - 16h20
Radiothérapie axillaire : quand et comment ?
Radiotherapy of the axilla: when and how.?
Dr Marc WIGODA, Israël u16h20 - 16h40
Les cancers du sein ≤ 1 cm. Place de l’hormonothérapie
adjuvante
Hormonotherapy in small lesions. Dr Ofra MAIMON, Israël u16h40 – 17h00
Place de la chimiothérapie adjuvante dans les petits
cancers du sein
Adjuvant chemotherapy in small lesion.
Dr David COEFFIC, France
u17h00 – 17h45
…. Symposium: TBD
u17h45 – 18h05
Panel discussion. Dr Marc WIGODA (Israël),
Dr Krishna CLOUGH (France), Dr Alain TOLEDANO (France)
u18h05 – 18h15
Conclusion and take home message. Pr Eli KONEN (Israël),
Pr Moïse NAMER (France), Pr Dan HERSHKO (Israël)
Vendredi 2 mai 2014 / Friday may 2nd
2014
u10h00 – 12h00 u SESSION 4
RCP : réunion de concertation multidisciplinaire
MCM : multidisciplinary consultation meeting
Modérateurs / Chairmen : Pr Zahava GALLIMIDI (Israël),
Pr Moise NAMER (France), Pr Jean-Michel TUBIANA (France)
u10h00 – 11h30 RCP franco-israélienne / Israeli-french MCM.
Dr Eric-Charles ANTOINE (France), Dr Jean-Yves SEROR (France),
Pr Efrat LEVY-LAHAD (Israël), Dr Joseph GLIGOROV (France),
Pr Jean-Luc DRAPE (France), Dr Luna KADURI (Israël),
Pr Eli KONEN (Israël), Dr Jean-Marc GUINEBRETIERE (France),
Dr Luc ROTENBERG (France), Dr Krishna CLOUGH (France),
Pr Dan HERSHKO (Israël), Dr Marc WIGODA (Israël)
u11h30 – 12h00
Conclusion and take home messages.
Pr Jean-Michel TUBIANA (France),
Dr Marc ESPIE (France)
I.M.E 124 Boulevard Exelmans - 75016 PARIS